BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 21740940)

  • 1. Mesenchymal stem cells engineered for cancer therapy.
    Shah K
    Adv Drug Deliv Rev; 2012 Jun; 64(8):739-48. PubMed ID: 21740940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.
    Nowakowski A; Drela K; Rozycka J; Janowski M; Lukomska B
    Stem Cells Dev; 2016 Oct; 25(20):1513-1531. PubMed ID: 27460260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulated stem cells for cancer therapy.
    Shah K
    Biomatter; 2013; 3(1):. PubMed ID: 23507920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles.
    Gao Z; Zhang L; Hu J; Sun Y
    Nanomedicine; 2013 Feb; 9(2):174-84. PubMed ID: 22772046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current progress in engineered and nano-engineered mesenchymal stem cells for cancer: From mechanisms to therapy.
    Shams F; Pourjabbar B; Hashemi N; Farahmandian N; Golchin A; Nuoroozi G; Rahimpour A
    Biomed Pharmacother; 2023 Nov; 167():115505. PubMed ID: 37716113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.
    Christodoulou I; Goulielmaki M; Devetzi M; Panagiotidis M; Koliakos G; Zoumpourlis V
    Stem Cell Res Ther; 2018 Dec; 9(1):336. PubMed ID: 30526687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells for anti-cancer drug delivery.
    Gjorgieva D; Zaidman N; Bosnakovski D
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):310-8. PubMed ID: 23688246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell-based therapies for cancer treatment: separating hope from hype.
    Stuckey DW; Shah K
    Nat Rev Cancer; 2014 Oct; 14(10):683-91. PubMed ID: 25176333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal/stem cells in drug therapy: New perspective.
    Sherman LS; Shaker M; Mariotti V; Rameshwar P
    Cytotherapy; 2017 Jan; 19(1):19-27. PubMed ID: 27765601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery.
    Schug C; Sievert W; Urnauer S; Müller AM; Schmohl KA; Wechselberger A; Schwenk N; Lauber K; Schwaiger M; Multhoff G; Wagner E; Nelson PJ; Spitzweg C
    Hum Gene Ther; 2018 Nov; 29(11):1287-1300. PubMed ID: 29724129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Mesenchymal Stem Cell/Nanomedicine Spheroid as an Active Drug Delivery Platform for Combinational Glioblastoma Therapy.
    Suryaprakash S; Lao YH; Cho HY; Li M; Ji HY; Shao D; Hu H; Quek CH; Huang D; Mintz RL; Bagó JR; Hingtgen SD; Lee KB; Leong KW
    Nano Lett; 2019 Mar; 19(3):1701-1705. PubMed ID: 30773888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.
    Kucerova L; Altanerova V; Matuskova M; Tyciakova S; Altaner C
    Cancer Res; 2007 Jul; 67(13):6304-13. PubMed ID: 17616689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mesenchymal stem cells-derived exosomes on tumor microenvironment: Tumor progression versus tumor suppression.
    Shojaei S; Hashemi SM; Ghanbarian H; Salehi M; Mohammadi-Yeganeh S
    J Cell Physiol; 2019 Apr; 234(4):3394-3409. PubMed ID: 30362503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells retrovirally transduced with prodrug-converting genes are suitable vehicles for cancer gene therapy.
    Ďuriniková E; Kučerová L; Matúšková M
    Acta Virol; 2014; 58(1):1-13. PubMed ID: 24717023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
    Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M
    J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare.
    Corsten MF; Shah K
    Lancet Oncol; 2008 Apr; 9(4):376-84. PubMed ID: 18374291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tweak to Treat: Reprograming Bacteria for Cancer Treatment.
    Sieow BF; Wun KS; Yong WP; Hwang IY; Chang MW
    Trends Cancer; 2021 May; 7(5):447-464. PubMed ID: 33303401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered mesenchymal stromal cells in cancer gene therapy.
    Matuskova M; Durinikova E; Altaner C; Kucerova L
    Bratisl Lek Listy; 2018; 119(4):221-223. PubMed ID: 29663820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor effects of canine adipose tissue-derived mesenchymal stromal cell-based interferon-β gene therapy and cisplatin in a mouse melanoma model.
    Seo KW; Lee HW; Oh YI; Ahn JO; Koh YR; Oh SH; Kang SK; Youn HY
    Cytotherapy; 2011 Sep; 13(8):944-55. PubMed ID: 21846298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.